-63% reduction from baseline at 52 weeks
3 patients still to complete 12 month trial in Q3
positive news
- Forums
- ASX - By Stock
- Ann: New positive interim data in Phase 2 study of SNT-5505
SNT
syntara limited
Add to My Watchlist
1.49%
!
6.6¢

-63% reduction from baseline at 52 weeks 3 patients still to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.6¢ |
Change
-0.001(1.49%) |
Mkt cap ! $108.8M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 6.6¢ | $18.96K | 285.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 120000 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 136479 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 76812 | 0.069 |
3 | 55190 | 0.068 |
1 | 74 | 0.067 |
2 | 153255 | 0.066 |
1 | 120000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 50000 | 2 |
0.066 | 62181 | 3 |
0.067 | 94444 | 1 |
0.068 | 98000 | 3 |
0.069 | 169137 | 3 |
Last trade - 10.09am 16/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |